94 related articles for article (PubMed ID: 24289080)
1. Local insulin application on the carotid artery inhibits neointima formation.
Chiang S; Breen DM; Guo J; Mori Y; Giacca A
Can J Physiol Pharmacol; 2013 Dec; 91(12):1086-94. PubMed ID: 24289080
[TBL] [Abstract][Full Text] [Related]
2. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
3. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
[TBL] [Abstract][Full Text] [Related]
4. Puerarin accelerates re-endothelialization in a carotid arterial injury model: impact on vasodilator concentration and vascular cell functions.
Cheng M; Li X; Guo Z; Cui X; Li H; Jin C; Zhang X; Guan X
J Cardiovasc Pharmacol; 2013 Oct; 62(4):361-8. PubMed ID: 23792702
[TBL] [Abstract][Full Text] [Related]
5. PI3K/p110α inhibition selectively interferes with arterial thrombosis and neointima formation, but not re-endothelialization: potential implications for drug-eluting stent design.
Holy EW; Jakob P; Eickner T; Camici GG; Beer JH; Akhmedov A; Sternberg K; Schmitz KP; Lüscher TF; Tanner FC
Eur Heart J; 2014 Mar; 35(12):808-20. PubMed ID: 24334406
[TBL] [Abstract][Full Text] [Related]
6. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.
Larifla L; Déprez I; Pham I; Rideau D; Louzier V; Adam M; Eloit M; Foucan L; Adnot S; Teiger E
J Gene Med; 2012 Jul; 14(7):459-67. PubMed ID: 22645072
[TBL] [Abstract][Full Text] [Related]
8. The CXCR4 antagonist POL5551 is equally effective as sirolimus in reducing neointima formation without impairing re-endothelialisation.
Hamesch K; Subramanian P; Li X; Dembowsky K; Chevalier E; Weber C; Schober A
Thromb Haemost; 2012 Feb; 107(2):356-68. PubMed ID: 22234341
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of n-butylidenephthalide on neointimal hyperplasia in balloon injured rat carotid artery.
Liu WS; Lin PC; Chang LF; Harn HJ; Shiuan D; Chiou TW; Jeng JR
Phytother Res; 2011 Oct; 25(10):1494-502. PubMed ID: 21365711
[TBL] [Abstract][Full Text] [Related]
10. Bis (aspirinato) zinc (II) complex successfully inhibits carotid arterial neointima formation after balloon-injury in rats.
Hegedűs P; Korkmaz S; Radovits T; Schmidt H; Li S; Yoshikawa Y; Yasui H; Merkely B; Karck M; Szabó G
Cardiovasc Drugs Ther; 2014 Dec; 28(6):533-9. PubMed ID: 25129612
[TBL] [Abstract][Full Text] [Related]
11. A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model.
Huang C; Mei H; Zhou M; Zheng X
Mol Med Rep; 2017 Jan; 15(1):21-28. PubMed ID: 27922693
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-Like Peptide-1 Receptor Activation Does not Affect Re-Endothelialization but Reduces Intimal Hyperplasia via Direct Effects on Smooth Muscle Cells in a Nondiabetic Model of Arterial Injury.
Eriksson L; Saxelin R; Röhl S; Roy J; Caidahl K; Nyström T; Hedin U; Razuvaev A
J Vasc Res; 2015; 52(1):41-52. PubMed ID: 25966620
[TBL] [Abstract][Full Text] [Related]
14. The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats.
Lu J; Ji J; Meng H; Wang D; Jiang B; Liu L; Randell E; Adeli K; Meng QH
Cardiovasc Diabetol; 2013 Apr; 12():58. PubMed ID: 23561047
[TBL] [Abstract][Full Text] [Related]
15. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
[TBL] [Abstract][Full Text] [Related]
16. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
17. Repetitive hypoglycemia increases circulating adrenaline level with resultant worsening of intimal thickening after vascular injury in male Goto-Kakizaki rat carotid artery.
Yasunari E; Mita T; Osonoi Y; Azuma K; Goto H; Ohmura C; Kanazawa A; Kawamori R; Fujitani Y; Watada H
Endocrinology; 2014 Jun; 155(6):2244-53. PubMed ID: 24684300
[TBL] [Abstract][Full Text] [Related]
18. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
Zhao FH; Chen YD; Jin ZN; Lu SZ
Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.
Jing L; Wang W; Zhang S; Xie M; Tian D; Luo X; Wang D; Ning Q; Lü J; Wang W
PLoS One; 2015; 10(3):e0118826. PubMed ID: 25760326
[TBL] [Abstract][Full Text] [Related]
20. Stent-based delivery of decoy oligodeoxynucleotides against activator protein-1 binding site decreased restenosis in rabbits.
Lin K; Zhao Z; Chen L
Pharmazie; 2013 Aug; 68(8):661-7. PubMed ID: 24020120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
